2030 Drug Research Trials 
Drug Discovery World
MAY 28, 2024
billion by 2030, growing at a CAGR of 15.3% from 2023 to 2030. The growth will in part by driven by an increase in the use of imaging modalities in drug research and development. The benefits of integrating AI with medical imaging for clinical trials. Download ‘Using imaging in drug discovery’ now.
Vial
MAY 20, 2024
Distinguishing the Roles of Preclinical vs. Clinical CROs in Clinical Research Randomized clinical trials are the gold-standard of evidence-based medicine, representing the culmination of the long, arduous drug development pipeline. billion by 2030 at a compound annual growth rate (CAGR) of 7.5% between 2024 and 2030.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Target Review
SEPTEMBER 21, 2023
If these genomes that codes for the proposed enzymes and biomolecules are critical to the worms as projected by Cotton et al (2016), then thus it creates countless opportunity for adulticidal drugs to be developed. She spent one year as a research assistant, focusing on NTDs and one year as a teaching assistant, focusing on Pharmacology.
Drug Discovery World
AUGUST 8, 2023
DDW’s Megan Thomas takes a deeper look into why India is ramping up drug discovery research, and explores the country’s innovation hubs of interest. In the global pharmaceuticals market, India ranks third worldwide for production by volume and the domestic pharmaceutical market is expected to reach US$120-130 billion by 2030 1.
The Pharma Data
APRIL 24, 2021
In 2020, we discovered another novel malaria therapy, INE963, which has an entirely new mechanism of action and is expected to begin clinical trials in 2021. R&D partnerships to combat drug-resistant malaria in Africa. INE963 is a fast-acting, long-lasting antimalarial that could potentially be delivered as a single-dose cure.
Expert insights. Personalized for you.
130 
Let's personalize your content